631 related articles for article (PubMed ID: 8978405)
1. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
Ripple MO; Henry WF; Rago RP; Wilding G
J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405
[TBL] [Abstract][Full Text] [Related]
2. Alteration in gamma-glutamyl transpeptidase activity and messenger RNA of human prostate carcinoma cells by androgen.
Ripple MO; Pickhardt PA; Wilding G
Cancer Res; 1997 Jun; 57(12):2428-33. PubMed ID: 9192821
[TBL] [Abstract][Full Text] [Related]
3. Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications.
Ripple MO; Hagopian K; Oberley TD; Schatten H; Weindruch R
Antioxid Redox Signal; 1999; 1(1):71-81. PubMed ID: 11225734
[TBL] [Abstract][Full Text] [Related]
4. Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells.
Ripple MO; Henry WF; Schwarze SR; Wilding G; Weindruch R
J Natl Cancer Inst; 1999 Jul; 91(14):1227-32. PubMed ID: 10413424
[TBL] [Abstract][Full Text] [Related]
5. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
6. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
7. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
8. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
9. Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies.
Lin H; Lu JP; Laflamme P; Qiao S; Shayegan B; Bryskin I; Monardo L; Wilson BC; Singh G; Pinthus JH
Int J Oncol; 2010 Oct; 37(4):761-6. PubMed ID: 20811696
[TBL] [Abstract][Full Text] [Related]
10. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
Berns EM; de Boer W; Mulder E
Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
[TBL] [Abstract][Full Text] [Related]
11. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
Miyake H; Hara I; Gleave ME; Eto H
Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
[TBL] [Abstract][Full Text] [Related]
12. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells.
Damassa DA; Lin TM; Sonnenschein C; Soto AM
Endocrinology; 1991 Jul; 129(1):75-84. PubMed ID: 2055206
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis.
Maramag C; Menon M; Balaji KC; Reddy PG; Laxmanan S
Prostate; 1997 Aug; 32(3):188-95. PubMed ID: 9254898
[TBL] [Abstract][Full Text] [Related]
15. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.
Qi H; Labrie Y; Grenier J; Fournier A; Fillion C; Labrie C
Mol Cell Endocrinol; 2001 Sep; 182(2):181-92. PubMed ID: 11514053
[TBL] [Abstract][Full Text] [Related]
16. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
[TBL] [Abstract][Full Text] [Related]
17. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Esquenet M; Heyns W; Rombauts W; Verhoeven G
Mol Cell Endocrinol; 1994 Sep; 104(2):153-62. PubMed ID: 7527352
[TBL] [Abstract][Full Text] [Related]
18. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
19. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.
Kokontis J; Takakura K; Hay N; Liao S
Cancer Res; 1994 Mar; 54(6):1566-73. PubMed ID: 7511045
[TBL] [Abstract][Full Text] [Related]
20. Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.
Fong CJ; Sutkowski DM; Braun EJ; Bauer KD; Sherwood ER; Lee C; Kozlowski JM
J Urol; 1993 May; 149(5):1190-4. PubMed ID: 7683344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
